Published in Perit Dial Int on April 26, 2010
Peritoneal changes in patients on long-term peritoneal dialysis. Nat Rev Nephrol (2013) 1.20
Protecting the peritoneal membrane: factors beyond peritoneal dialysis solutions. Nat Rev Nephrol (2012) 0.87
Benfotiamine protects against peritoneal and kidney damage in peritoneal dialysis. J Am Soc Nephrol (2011) 0.86
Hyperbranched polyglycerol is an efficacious and biocompatible novel osmotic agent in a rodent model of peritoneal dialysis. Perit Dial Int (2013) 0.82
Previous renal replacement therapy time at start of peritoneal dialysis independently impact on peritoneal membrane ultrafiltration failure. Int J Nephrol (2011) 0.77
Evaluation of Renal-Hepatic Functional Indices and Blood Pressure Based on the Progress of Time in a Rat Model of Chronic Kidney Disease. Nephrourol Mon (2016) 0.75
Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int (2010) 12.06
A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant (2003) 2.95
High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant (2007) 2.91
Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study. Nephrol Dial Transplant (2010) 2.64
Estimation of residual glomerular filtration rate in dialysis patients from the plasma cystatin C level. Nephrol Dial Transplant (2007) 2.53
The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in The Netherlands. Am J Kidney Dis (2004) 2.40
Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver. J Clin Invest (2012) 2.33
Time-dependent reasons for peritoneal dialysis technique failure and mortality. Perit Dial Int (2010) 2.17
Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int (2002) 2.12
Computed tomographic findings characteristic for encapsulating peritoneal sclerosis: a case-control study. Perit Dial Int (2009) 1.96
Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients. Nephrol Dial Transplant (2010) 1.90
CCR5 deletion protects against inflammation-associated mortality in dialysis patients. J Am Soc Nephrol (2009) 1.88
Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int (2003) 1.87
Analysis of the prevalence and causes of ultrafiltration failure during long-term peritoneal dialysis: a cross-sectional study. Perit Dial Int (2004) 1.86
Social support predicts survival in dialysis patients. Nephrol Dial Transplant (2006) 1.84
Early diagnostic markers for encapsulating peritoneal sclerosis: a case-control study. Perit Dial Int (2010) 1.82
Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients. Nephrol Dial Transplant (2006) 1.76
Dietary protein requirements and dialysate protein losses in chronic peritoneal dialysis patients. Perit Dial Int (2007) 1.71
The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD )-2. Am J Kidney Dis (2003) 1.66
Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis. Am J Kidney Dis (2002) 1.62
Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol (2004) 1.62
The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients. Am J Kidney Dis (2005) 1.60
Evaluation of a new immortalized human fetal liver cell line (cBAL111) for application in bioartificial liver. J Hepatol (2007) 1.55
Influence of dialysate on gastric emptying time in peritoneal dialysis patients. Perit Dial Int (2002) 1.55
How to adjust for comorbidity in survival studies in ESRD patients: a comparison of different indices. Am J Kidney Dis (2002) 1.49
Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis: analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis 2. J Am Soc Nephrol (2003) 1.48
Effects of icodextrin on the peritoneal membrane. Nephrol Dial Transplant (2010) 1.48
Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. J Ren Nutr (2009) 1.46
Encapsulating peritoneal sclerosis: the state of affairs. Nat Rev Nephrol (2011) 1.44
Fluid loss does not explain coagulation activation during air travel. Thromb Haemost (2008) 1.38
The MDRD formula does not reflect GFR in ESRD patients. Nephrol Dial Transplant (2010) 1.38
Organic anion transporting polypeptide 1a/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs. J Clin Invest (2010) 1.37
Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis. Perit Dial Int (2006) 1.33
Damage of the endothelial glycocalyx in dialysis patients. J Am Soc Nephrol (2012) 1.29
Altered disposition of acetaminophen in mice with a disruption of the Mrp3 gene. Hepatology (2005) 1.28
Association between a self-rated health question and mortality in young and old dialysis patients: a cohort study. Am J Kidney Dis (2008) 1.27
Full loss of residual renal function causes higher mortality in dialysis patients; findings from a marginal structural model. Nephrol Dial Transplant (2011) 1.22
Peritoneal changes in patients on long-term peritoneal dialysis. Nat Rev Nephrol (2013) 1.20
The transcriptomic signature of fasting murine liver. BMC Genomics (2008) 1.19
Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up. J Am Soc Nephrol (2007) 1.18
Adjustment for comorbidity in studies on health status in ESRD patients: which comorbidity index to use? J Am Soc Nephrol (2003) 1.16
Bone alkaline phosphatase and mortality in dialysis patients. Clin J Am Soc Nephrol (2011) 1.13
Does the biocompatibility of the peritoneal dialysis solution matter in assessment of peritoneal function? Perit Dial Int (2007) 1.11
Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor-α are similarly associated with survival in haemodialysis patients. Nephrol Dial Transplant (2010) 1.09
Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the in vivo elimination of methotrexate and its main toxic metabolite 7-hydroxymethotrexate. Clin Cancer Res (2008) 1.07
Microalbuminuria in adults after prenatal exposure to the Dutch famine. J Am Soc Nephrol (2004) 1.06
Blood pressure response to uncomplicated hemodialysis: the importance of changes in stroke volume. Nephron Clin Pract (2004) 1.06
Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition. BMC Nephrol (2011) 1.04
Quantification of free water transport in peritoneal dialysis. Kidney Int (2004) 1.03
Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients. Nephrol Dial Transplant (2008) 1.03
A positive effect of AII inhibitors on peritoneal membrane function in long-term PD patients. Nephrol Dial Transplant (2008) 1.02
Functionally overlapping roles of Abcg2 (Bcrp1) and Abcc2 (Mrp2) in the elimination of methotrexate and its main toxic metabolite 7-hydroxymethotrexate in vivo. Clin Cancer Res (2009) 1.01
Effect of an increase in C-reactive protein level during a hemodialysis session on mortality. J Am Soc Nephrol (2004) 1.00
When to start dialysis treatment: where do we stand? Perit Dial Int (2005) 1.00
Determinants of peritoneal solute transport rates in newly started nondiabetic peritoneal dialysis patients. Perit Dial Int (2004) 1.00
Peritoneal albumin and protein losses do not predict outcome in peritoneal dialysis patients. Clin J Am Soc Nephrol (2010) 0.99
Cyclosporin A induces peritoneal fibrosis and angiogenesis during chronic peritoneal exposure to a glucose-based, lactate-buffered dialysis solution in the rat. Blood Purif (2007) 0.98
Recombinant human soluble tumor necrosis factor-alpha receptor fusion protein partly attenuates ventilator-induced lung injury. Shock (2009) 0.97
Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate. Am J Physiol Renal Physiol (2009) 0.97
Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters. Am J Nephrol (2007) 0.97
Low cholesterol in dialysis patients--causal factor for mortality or an effect of confounding? Nephrol Dial Transplant (2011) 0.96
Dextran antibodies in peritoneal dialysis patients treated with icodextrin. Perit Dial Int (2002) 0.96
Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions. Adv Perit Dial (2003) 0.96
Symptom clusters in incident dialysis patients: associations with clinical variables and quality of life. Nephrol Dial Transplant (2008) 0.96
Sex differences in the impact of diabetes on mortality in chronic dialysis patients. Nephrol Dial Transplant (2010) 0.96
Trans-intestinal cholesterol efflux is not mediated through high density lipoprotein. J Lipid Res (2012) 0.95
Disturbed mineral metabolism is associated with muscle and skin complaints in a prospective cohort of dialysis patients. Nephrol Dial Transplant (2007) 0.95
The time course of peritoneal transport parameters in peritoneal dialysis patients who develop encapsulating peritoneal sclerosis. Nephrol Dial Transplant (2010) 0.94
Predictors of survival in anuric peritoneal dialysis patients. Kidney Int (2005) 0.94
Peritoneal function and assessment of reference values using a 3.86% glucose solution. Perit Dial Int (2003) 0.94
The value of estimated GFR in comparison to measured GFR for the assessment of renal function in adult patients with Fabry disease. Nephrol Dial Transplant (2010) 0.94
Is obesity associated with a survival advantage in patients starting peritoneal dialysis? Contrib Nephrol (2009) 0.93
Excellent agreement between C-reactive protein measurement methods in end-stage renal disease patients--no additional power for mortality prediction with high-sensitivity CRP. Nephrol Dial Transplant (2007) 0.93
Subjective global assessment of nutritional status is strongly associated with mortality in chronic dialysis patients. Am J Clin Nutr (2009) 0.93
Patients' representations of their end-stage renal disease: relation with mortality. Nephrol Dial Transplant (2009) 0.93
Haemodialysis catheters increase mortality as compared to arteriovenous accesses especially in elderly patients. Nephrol Dial Transplant (2011) 0.93
Impact of ACE inhibitors and AII receptor blockers on peritoneal membrane transport characteristics in long-term peritoneal dialysis patients. Perit Dial Int (2007) 0.93
Comparing mortality in renal patients on hemodialysis versus peritoneal dialysis using a marginal structural model. Int J Biostat (2010) 0.93
Serum troponin T concentration as a predictor of mortality in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis (2006) 0.92
Incidence of recombinant erythropoietin (EPO) hyporesponse, EPO-associated antibodies, and pure red cell aplasia in dialysis patients. Kidney Int (2005) 0.92